Learning pointsAortic pseudocoarctation is a rare entity, distinguished from true coarctation (CoA) by the absence of haemodynamically significant narrowing of the descending aorta and of the typical clinical findings found in aortic CoA.Associated congenital cardiac anomalies, such as bicuspid aortic valve, are frequent and should be looked for.Management is conservative and should focus on the optimal control of arterial hypertension.

Introduction
============

Aortic pseudocoarctation (PsCoA) is a rare entity, belonging to the same spectrum of disease as aortic coarctation (CoA). As the haemodynamic significance of both of these diseases is different, management is accordingly not the same. Caregivers should be aware that these entities do not only concern a paediatric population as diagnosis can be missed until adulthood, in particular in the case of PsCoA.[@ytaa105-B1] Due to the frequent association with other congenital heart anomalies, such as bicuspid aortic valve (BAV), which increases the risk of serious cardiovascular complications, prompt detection and management is essential.

Timeline
========

  Time                                                                                                                                                                     Events
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Admission (Day 0)                                                                                                                                                        Presentation at the emergency department with retrosternal chest pain since the previous day
  The patient had symmetrically elevated blood pressure (BP) and a 3/6 systolic murmur with point maximum at the third left lower sternal border on cardiac auscultation   
  The 12-lead electrocardiogram and lab results were suggestive of cardiac ischaemia                                                                                       
  Admission + 3 h                                                                                                                                                          Coronary angiography showed an occlusion of the obtuse marginal artery for which a strategy of conservative management was chosen
  Aortography showed a tortuous descending thoracic aorta (DA) as well as a dilated ascending aorta (AA) with an abnormal aortic valve opening                             
  Admission + 4 h                                                                                                                                                          Thoracic computed tomography angiography ruled out an aortic dissection and confirmed the presence of a 'kinking' of the DA distal to the subclavian artery
  Admission + 4.5 h                                                                                                                                                        Admission to the intensive care unit
  Day 1                                                                                                                                                                    Transthoracic and transoesophageal echocardiography: Left ventricular hypertrophy with preserved left ventricular ejection fraction and no wall motion abnormalitiesBicuspid aortic valve with mild stenosis and mild regurgitationDilated AA
  Day 7                                                                                                                                                                    Patient discharged after optimizing BP control with oral medication
  Periodical follow-up arranged                                                                                                                                            

Case presentation
=================

A 60-year-old south-Asian male, with past medical history of poorly controlled blood pressure (BP) under an angiotensin II receptor antagonist (sartan), presented to the emergency department complaining of retrosternal chest pain that appeared the previous day. Vital parameters were relevant for elevated BP (left arm 178/108 mmHg, right arm 172/100 mmHg). Physical examination was remarkable for a 3/6 systolic murmur with point maximum at the third left lower sternal border. No radial-radial (RR) or radio-femoral (RF) delay was found. The dorsalis pedis and posterior tibial artery pulses were palpable bilaterally. Bilateral upper limb and thigh BP measurement did not show any discrepancies and the patient did not report any claudication. The 12-lead electrocardiogram showed a complete right bundle branch block and left anterior hemiblock, as well as negative T-waves from V4 to V6 suggestive of ischaemia ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Figure A*). High-sensitive cardiac Troponin T was elevated at 495 ng/L (normal value: \<14 ng/L). As an acute coronary syndrome (ACS) was evident, the patient underwent urgent coronary angiogram through a right femoral artery access. The exam revealed an occlusion of the obtuse marginal artery ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Videos S1 and S2*). Due to the small calibre of the vessel and the absence of functional repercussion in the ventriculography, a strategy of conservative management was chosen.

Furthermore, the descending thoracic aorta (DA) was noted to be tortuous when advancing the guidewire (*[Figure 1](#ytaa105-F1){ref-type="fig"}*). Aortography confirmed this finding and additionally showed a dilated ascending aorta (AA) with an abnormal aortic valve opening ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Videos S3 and S4*). A thoracic computed tomography (CT) angiogram performed subsequently ruled out an aortic dissection and confirmed the presence of a 'kinking' of the DA distal to the subclavian artery, with a \<50% of narrowing relative to the diameter of the aorta at the diaphragm level (*[Figure 2A--C](#ytaa105-F2){ref-type="fig"}*). The diameter of the AA was measured at 40 mm. The patient was subsequently admitted to the intensive care unit.

![Fluoroscopic image, taken during the coronary angiography, showing the guidewire having an acute angle (arrow) as it was advanced in the descending aorta from a right femoral artery access.](ytaa105f1){#ytaa105-F1}

![(*A--C*) Volume-rendered 3D reconstructions of a thoracic computed tomography angiogram showing a tortuosity or 'kinking' of the descending aorta, distal to the left subclavian artery, without any developed collateral circulation.](ytaa105f2){#ytaa105-F2}

A transthoracic echocardiography performed on the following day showed a concentric left ventricular hypertrophy (LVH) without any wall motion abnormalities (*[Figure 3](#ytaa105-F3){ref-type="fig"}*) ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Videos S5 and S6*). The aortic valve was severely calcified with mild stenosis and mild regurgitation. The diameter of the AA was measured at 40 mm as well. A transoesophageal echocardiography performed later confirmed a Type I L-R BAV (raphe between the left and right coronary sinus) according to the Sievers classification,[@ytaa105-B2] with a planimetric opening area of 1.8 cm^2^ (*[Figure 4](#ytaa105-F4){ref-type="fig"}*) ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Video S7*). The narrowest diameter of the DA was measured at 11 mm as in the CT (*[Figure 5](#ytaa105-F5){ref-type="fig"}*) ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *Video S8*). As the angle between the proximal and distal part of the DA was too acute, no Doppler gradients were measurable.

![Transthoracic echocardiography parasternal long*-*axis view showing hypertrophy of the anteroseptal and inferolateral left ventricular walls, as well as a calcified aortic valve.](ytaa105f3){#ytaa105-F3}

![Transoesophageal echocardiography short*-*axis view of the aortic valve showing a Type I L-R (raphe between the left and right coronary sinus) bicuspid aortic valve.](ytaa105f4){#ytaa105-F4}

![Transoesophageal echocardiography using simultaneous biplane imaging (X-plane) showing the narrowing of the descending aorta, measured at 11 mm.](ytaa105f5){#ytaa105-F5}

The patient could be discharged a week following admission under dual antiplatelet therapy, statin, low-dose sartan, and low-dose beta-blocker, with optimal BP control (at discharge: left arm 132/78 mmHg, right arm 128/70 mmHg) under this regimen.

Discussion
==========

The clinical findings in our patient, especially the absence of a pulse delay (RR and RF) and BP discrepancies between the four extremities, suggested the absence of significant blood flow obstruction through the kinked DA. Consolidating this hypothesis, no collateral circulation was found in the thoracic CT angiography. All in all, the diagnosis of PsCoA was made.

Coarctation and PsCoA are part of a common spectrum of disease, with the difference being the functional repercussion of the aortic narrowing. While true CoA is defined by congenital narrowing of the DA at the aortic isthmus with clinical features such as upper body systolic hypertension, lower body hypotension, a BP gradient between upper and lower extremities, RF pulse delay, and palpable collateral circulation,[@ytaa105-B3] these are typically not found in PsCoA.[@ytaa105-B1] The mean age of diagnosis of PsCoA is 43 years,[@ytaa105-B1] while CoA may go undiagnosed as late as in the adult life if it is not severe or if collateral circulation develops. Untreated CoA can lead to a compensatory LVH due to the increased afterload and hence to hypertensive vascular complications like premature coronary artery disease.[@ytaa105-B3]

Bicuspid aortic valve is the most common congenital heart disease with a prevalence of 1--2%.[@ytaa105-B4] The prevalence of CoA is of 0.03%[@ytaa105-B3] and that of PsCoA is unknown but probably even less, as a recent systematic review[@ytaa105-B1] only reported 18 published cases of PsCoA in the adult population. Both CoA and PsCoA have reported association with BAV.[@ytaa105-B4] The Type I L-R BAV is the most common pattern[@ytaa105-B10] and is additionally the only type reported in CoA.[@ytaa105-B11] About 50--75% of patients with CoA have a BAV, whereas only 7% of patients with BAV have a concomitant CoA.[@ytaa105-B4] This association increases the risk of developing aortic dilatation and dissection, compared to BAV alone. If an association between a specific type of BAV with PsCoA exists or not is, to our knowledge, unknown.

Specific guidelines regarding management of PsCoA are lacking, and therefore management should follow the 2010 ESC guidelines on true CoA.[@ytaa105-B3]^,^[@ytaa105-B12] Indications for repair are a non-invasive pressure difference \>20 mmHg between the upper and lower limbs with upper limb hypertension, pathologic BP response to exercise or LVH \[class of recommendation (CoR) I, level of evidence (LoE) A\]. In hypertensive patients with a ≥50% narrowing of the aortic lumen relative to the reference aortic diameter at the diaphragm level, intervention should be considered (CoR IIa, LoE C). The invasive measurement of a peak-to-peak gradient across the CoA orifice by catheterization, with a value of \>20 mmHg being haemodynamically relevant, is not considered in the 2010 ESC guidelines. Concerning the management of BAV with associated aortic root dilatation, the 2014 ESC guidelines[@ytaa105-B4] recommend surgery of the AA in case of an aortic root or AA diameter of \>45 mm if aortic valve replacement is planned (CoR I, LoE C), or if the diameter is \>50 mm with the presence of risk factors such as CoA or hypertension (CoR I, LoE C).

Our patient had LVH as a sign of increased afterload. To determine if he is suffering from essential hypertension or secondary hypertension due to the PsCoA or both, is difficult. The fact that BP could be adequately controlled under low-dose sartan/beta-blocker bi-therapy is reassuring but does not support any of the aetiologies. A regular monitoring of BP at home with a target of \<140/90 mmHg as per the 2018 ESC guidelines was advised.[@ytaa105-B13] As the risk of aortic dilatation and progression to aneurysm formation and eventually rupture is even higher in this patient due to the combination of a BAV, AA dilatation, and PsCoA, a stricter BP target of \<130/80 mmHg should, in our opinion, be considered. Avoidance of isometric exercise comprising a high static load was pragmatically recommended (CoR III, LoE C, if aortic \>40 mm in the presence of a BAV or elastopathy). Screening for BAV of first-degree relatives was advised (CoR IIa, LoE C).

A beta-blocker therapy was begun in the setting of the ACS. Of note, it may also be considered in patients with BAV and dilated aortic root \>40 mm (CoR IIb, LoE C). Beta-blockers and sartans---in particular losartan---have shown efficacy in preventing progression of aortic root dilatation in patients with Marfan syndrome[@ytaa105-B14]^,^[@ytaa105-B15] and their use is therefore extended to other aetiologies.

A periodical clinical and echocardiographic follow-up, including a baseline imaging assessment of the entire aorta (CoR I, LoE C), was scheduled. Annual surveillance of the aorta for the development of an aortic aneurysm is recommended.[@ytaa105-B1] An uncontrollable hypertension or progression of the LVH, despite adequate medical therapy, should prompt a surgical correction of the PsCoA, as the contribution of the latter to the increased afterload would, in this case, be manifest.

Conclusion
==========

Pseudocoarctation is a rare diagnosis which shares a common spectrum of disease with CoA. It consists of a 'non-severe' CoA, with lower impact on the left ventricular afterload and hence lacks adaptive mechanisms such as the development of collateral circulation. The presence of concomitant BAV or of other congenital heart diseases is not unusual, and should be investigated. As specific guidelines for the management of PsCoA are lacking, decisions should be made based on a case by case evaluation, following the 2010 ESC guidelines on CoA.[@ytaa105-B3]

One should bear in mind that CoA, and PsCoA by extension, are rare causes of secondary hypertension[@ytaa105-B15] that should be considered in case of a suggestive clinical picture. Prompt detection and management can prevent deadly cardiovascular complications.
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